Home | About the eMC | Help | Mobile
eMC - trusted, up to date and comprehensive information about medicines
Link to eMC medicine guides website
eMC homepage
Advanced search
Get Medicines Compendium UK app here

Aurobindo Pharma Ltd
Odyssey Business Park, Ares Block, West End Road, South Ruislip, Middlesex, HA4 6QD
Telephone: + 44 (0)208 845 8811
Fax: +44 (0)208 845 8735
WWW: http://www.aurobindo.com
Medical Information Direct Line: +44 (0)208 839 0959
Medical Information e-mail: medinfo@aurobindo.com
Customer Care direct line: +44 (0)208 845 8811
Medical Information Fax: +44 (0)208 845 8795

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?
Patient Information Leaflet last updated on the eMC: 10/05/2012
PIL Co-Amilofruse 2.5/20mg, 5/40mg and 10/80mg Tablets

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 10/05/2012 and displayed until Current
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change of contra-indications
  • Change to side-effects
  • Change to drug interactions
Updated on 18/08/2011 and displayed until 10/05/2012
Reasons for adding or updating:
  • Change due to harmonisation of PIL.
Updated on 13/10/2010 and displayed until 18/08/2011
Reasons for adding or updating:
  • New PIL for eMC ie a PIL for an existing product but one that is new to the eMC

Active Ingredients/Generics

 
  amiloride hydrochloride
  furosemide